AlphaMol Science
PrivateLast Round
Series B
Nov 1, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AlphaMol Science operates in Healthcare & Life Sciences and is based in Allschwil. Its latest recorded funding round was a Series B round in November 2025.
AlphaMol Science is a biotechnology company that leverages computational biology, artificial intelligence, and medicinal chemistry to accelerate G protein-coupled receptor (GPCR) drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlphaMol Science Comparables
Compare AlphaMol Science with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InterAx Biotech | 83% | |
| In Virtuo Laboratories SA | 80% | |
| Genesis Therapeutics | 80% |
For institutional investors. Book with your work email.
AlphaMol Science Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 1, 2025 | ||||
| Series A | Aug 24, 2023 | ||||
| Angel | May 7, 2021 |
For institutional investors. Book with your work email.
AlphaMol Science Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Healthcare Capital | Series A |
| Huaqian Capital | Series A |
| CICC Capital | Series B |
| Shenzhen New Henglida Capital Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2025
Raised Series B round with CICC Capital as an investor.
- Jun 1, 2025
Monthly visitors grew 56% MoM.
For institutional investors. Book with your work email.
AlphaMol Science Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AlphaMol Science's valuation, stock price, and market status.
Is AlphaMol Science a public or private company?
AlphaMol Science is a private company.
What is the current stock price of AlphaMol Science?
AlphaMol Science is a private company, so its shares have no public market price. Caplight tracks AlphaMol Science's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AlphaMol Science worth (valuation)?
Valuation information for AlphaMol Science is not publicly available.
Can I buy AlphaMol Science stock?
AlphaMol Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AlphaMol Science's last funding round?
AlphaMol Science's most recent funding round was Series B on November 1, 2025.
Who are the main investors in AlphaMol Science?
Key investors in AlphaMol Science include Shanghai Healthcare Capital.
Will AlphaMol Science IPO soon?
No public IPO plans have been announced for AlphaMol Science.
How can I track AlphaMol Science secondary market activity?
Caplight tracks bids, offers, and trades in AlphaMol Science's shares on secondary markets.